Skip to main content
Clinical Trials/NCT03796988
NCT03796988
Completed
Not Applicable

Autologous Regeneration of Tissue (ART) for Wound Healing

University of Miami1 site in 1 country22 target enrollmentSeptember 14, 2018
ConditionsWound of Skin

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Wound of Skin
Sponsor
University of Miami
Enrollment
22
Locations
1
Primary Endpoint
Change of Pain on Harvesting of Skin at Donor Site.
Status
Completed
Last Updated
last year

Overview

Brief Summary

The purpose of this research study is to learn about a new device, Autologous Regeneration of Tissue (ART), for collecting skin grafts from participant's own skin.

Registry
clinicaltrials.gov
Start Date
September 14, 2018
End Date
March 19, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hadar Lev-Tov

Assistant Professor

University of Miami

Eligibility Criteria

Inclusion Criteria

  • Adults from 18 to 90 years of age.
  • Patients that have a chronic wound in any area of the body defined as having been present for at least 30 days of duration.
  • Able and willing to give consent for the study.

Exclusion Criteria

  • Pregnant women (Urine hCG test will be performed at baseline on women of child bearing potential).
  • Adults unable to consent.
  • Prisoners.
  • Subjects requiring concurrent systemic antimicrobials during the study period for any infection.
  • Subjects with leg lesions and clinically significant and unreconstructed peripheral arterial disease.
  • Subjects who are receiving immunosuppressive agents, radiation therapy, or cytotoxic agents.
  • Subjects who require treatment for a primary or metastatic malignancy (other than squamous or basal cell carcinoma of the skin).
  • Subjects with other conditions considered by the investigator to be reasons for disqualification that may jeopardize subject safety or interfere with the objectives of the trial (e.g., acute illness or exacerbation of chronic illness, lack of motivation, history of poor compliance).

Outcomes

Primary Outcomes

Change of Pain on Harvesting of Skin at Donor Site.

Time Frame: Baseline, Day 56

Pain assessed using a Pain Visual Analog Scale (VAS) with a score ranging from 0 millimeters (no pain) to 100 millimeters (worst possible pain)

Time to Healing of Donor Sites

Time Frame: Up to Day 56

At each weekly visit, the donor site will be assessed for healing based on clinical observation as measured by number of days from procedure.

Secondary Outcomes

  • Wound Healing of Recipient Site(Up to Day 56)
  • Histologic Evaluation(Up to Day 56)

Study Sites (1)

Loading locations...

Similar Trials